BALDONI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 627
EU - Europa 477
AS - Asia 185
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.290
Nazione #
US - Stati Uniti d'America 627
SE - Svezia 152
IE - Irlanda 124
CN - Cina 109
TR - Turchia 67
IT - Italia 45
DE - Germania 41
UA - Ucraina 37
GB - Regno Unito 34
FR - Francia 16
BE - Belgio 14
FI - Finlandia 10
IN - India 4
VN - Vietnam 2
ES - Italia 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.290
Città #
Jacksonville 144
Chandler 127
Dublin 124
Ann Arbor 62
Izmir 34
Nanjing 32
Woodbridge 30
Boardman 25
Wilmington 23
Ashburn 18
Lawrence 18
Princeton 18
San Mateo 17
Brussels 14
New York 12
Nanchang 11
Verona 11
Hangzhou 10
L'aquila 10
Perugia 7
Hebei 6
Milan 6
Mountain View 6
Shenyang 6
Jiaxing 5
Lanzhou 5
Los Angeles 5
Ningbo 5
Des Moines 4
Falls Church 4
Zhengzhou 4
Kunming 3
Tianjin 3
Auburn Hills 2
Changsha 2
Dearborn 2
Dong Ket 2
Düsseldorf 2
Fremont 2
Fuzhou 2
Jinan 2
Redwood City 2
Seattle 2
Shanghai 2
Taizhou 2
Amsterdam 1
Beijing 1
Bremen 1
Gandhi Nagar 1
Guangzhou 1
Houston 1
Jinhua 1
Kuala Lumpur 1
Leeds 1
Madrid 1
Philadelphia 1
Prato 1
Pune 1
San Giovanni in Persiceto 1
Strasbourg 1
Taiyuan 1
Tokyo 1
Totale 850
Nome #
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 97
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 96
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 86
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma? 84
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 82
Constitutive phosphorilation of the active Notch1 intracellular domain in chronic lymphocytic leukemia with Notch1 mutation 78
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 76
Notch1 modulates MSC-mediated regulatory T cell induction 72
Notch1 PEST domain mutation is an adverse prognostic factor in B-CLL 70
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 70
NOTCH signalling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 69
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 68
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation 67
The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. 66
T regulatory cell separation for clinical application 65
A revised Notch1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 58
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 55
Notch and NF-kB interplay in Chronic Lymphocytic Leukemia is independent of genetic lesion 47
Totale 1.306
Categoria #
all - tutte 4.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 0 1 44
2019/2020178 39 0 20 6 2 20 47 3 18 5 0 18
2020/2021193 6 18 0 25 20 15 25 1 18 21 27 17
2021/2022191 20 8 72 22 5 3 5 9 5 9 6 27
2022/2023374 27 29 5 45 35 31 0 25 158 1 13 5
2023/202459 9 5 1 9 3 14 0 15 0 3 0 0
Totale 1.306